Phase Space Research

HIVE Digital Technologies

HIVE · Investment summary · as of 3 August 2026

Priced for an operating path the record does not support

Portfolio decision
No position
Price · 3 August 2026
$2.89
12-month target
$4.14 +43%
Expected return
-15.0%
Next decision point
5 years, to the FY2031 exit year and the 2031 note maturityThesis resolution horizon

Business type: Transition · cyclical or commodity-sensitive

The business does not meet the quality standard for its economic type.

Investment view

At $2.89, HIVE requires a 94% five-year revenue growth rate to justify its enterprise value — more than the business has ever demonstrated, at 47%.

The disagreement with the market is not about revenue. HIVE's revenue trebled in one year and its GAAP gross profit got more negative in absolute terms (-$39.342m -> -$62.528m). The question is whether this revenue can ever carry a positive operating margin.

The conditions that would settle the disagreement are dated 5 years, to the FY2031 exit year and the 2031 note maturity.

The value rests on an exit multiple of 6.6x, a terminal operating margin of -21% and a 13.5% cost of capital. Move any one of them materially and the conclusion moves with it, which is why the required-versus-demonstrated test above carries more weight here than the point value.

The strongest argument against this view: bitcoin price and GPU residual value, against a balance sheet that has been levered since the last underwriting.

Underwriting bridge

QuestionEvidence-based conclusion
What drives the business?The disagreement with the market is not about revenue. HIVE's revenue trebled in one year and its GAAP gross profit got more negative in absolute terms (-$39.342m -> -$62.528m).
What do we forecast?Revenue growth of 47% demonstrated; a terminal operating margin of -21%; an exit multiple of 6.6x.
What does Street forecast?Not determined — no consensus estimates are joined to this record
Where do we differ?On terminal margin, the difference between what the price requires and what the business has demonstrated is -49.6 percentage points.
What is it worth?Twelve-month target $4.14, +43% from the struck price. Scenario-weighted expected return net of costs -15.0%.
Why now?Date not announced — no dated event that would resolve the disagreement is on file

What must go right

  1. By 30 June 2026The condition does not occur: BUZZ HPC revenue reaches at least $73m ANNUALISED - the Bell/Cohere run-rate implied by $220m over three years - evidencing that the executed TCV converts to recognised revenue on schedule rather than repeating FY2026, in which a claimed $35m of ARR delivered $19.5m of revenue.Where it stands: Not determined — no current reading of this metric is on file
  2. By FY2027 Q2 (Dec-2026) and Q3 (Mar-2027) 6-K filingsThe condition does not occur: us-gaap:GrossProfit is POSITIVE for two consecutive fiscal quarters. HIVE has not achieved this since FY2022.Where it stands: Not determined — no current reading of this metric is on file
  3. By any filing through FY2029Signed, dated and quantified contracted revenue no more than 40% of trailing-twelve-month revenue.Where it stands: Not determined — no current reading of this metric is on file

Catalysts and falsifiers

Date or windowEventThesis confirmed ifThesis weakened or refuted if
FY2027 Q2 (Dec-2026) and Q3 (Mar-2027) 6-K filingsUs-gaap:GrossProfit is POSITIVE for two consecutive fiscal quarters.…Neither leg of the condition opposite is met at this dateus-gaap:GrossProfit is POSITIVE for two consecutive fiscal quarters. HIVE has not achieved this since FY2022.
30 June 2026BUZZ HPC revenue reaches at least $73m ANNUALISED - the Bell/Cohere…Neither leg of the condition opposite is met at this dateBUZZ HPC revenue reaches at least $73m ANNUALISED - the Bell/Cohere run-rate implied by $220m over three years…
any filing through FY2029Signed, dated and quantified contracted revenue exceeds 40% of…Signed, dated and quantified contracted revenue no more than 40% of trailing-twelve-month revenue.Signed, dated and quantified contracted revenue exceeds 40% of trailing-twelve-month revenue.
FY2027 10-K onwardFree cash flow (CFO less capex) is positive for a full fiscal year.…Neither leg of the condition opposite is met at this dateFree cash flow (CFO less capex) is positive for a full fiscal year. Never achieved: -46.9% of revenue in FY2024, -90.3%…

Risk and sell discipline

Impairment case

Bitcoin price and GPU residual value, against a balance sheet that has been levered since the last underwriting. HIVE's mining gross margin is negative INCLUDING depreciation (at most -25.3% in FY2026) and the fleet consumed $170.4m of depreciation on $297.8m of revenue. The treasury that funded the last capex cycle is gone ($181.1m -> $10.8m). Since 16 April 2026 HIVE has issued $230m of 0% exchangeable notes due 2031, with a holder put in mid-2030, to fund GPUs for a THREE-YEAR contract. If bitcoin sustains lower and the Bell/Cohere GPUs do not re-contract at year three, the equity sits behind $230m of notes plus $42.9m of other debt against a fleet whose accounting life is shorter than the notes. The failure mode is no longer 'HIVE can only be diluted' - which is what the prior record concluded when funded debt was near zero. It can now be impaired.

Estimated probability 30%, against the 14% level at which the position would be resized. It sits above that level, so this case could not be carried at full size.

Fundamental invalidation

Falsifiable and fundamental — not one of them is a price condition.

Price-based risk trigger

A daily close below $2.17 triggers an immediate review of the thesis and pauses additional buying. It is not an automatic sell unless a separate fundamental invalidation condition has been breached.

Upside sell discipline

No position is initiated, so no trim rule is live. Were one held: exit on valuation and opportunity cost when EV/TTM revenue exceeds 4.0x (2.70x today) or when a re-run puts the required terminal EBIT margin at the identity ceiling above 35% (28.8% today). On approach to the $4.14 target the case is reviewed rather than added to; a target reached is a reason to re-examine the position, not to hold it by default. The position is trimmed once forward expected return falls below 0% net of costs, because the capital has a better use elsewhere in the book.

Investment criteria

CriteriaStatusInvestment meaning
QualityNot metIs the business worth owning under its declared economic type?
ValuationNot metIs the operating path required by today's price achievable?
LiquidityMetCan the intended position be built and exited in the right vehicle?
DownsideMetBitcoin price and GPU residual value, against a balance sheet that has been levered since the last underwriting.
MomentumNot determinedDoes price action support or complicate entry timing? Not established on the evidence on file.
CatalystNot determinedIs there a dated event that resolves the disagreement? Not established on the evidence on file.
ConsensusNot determinedIs the house-versus-Street disagreement identified and quantified? Not established on the evidence on file.

Quality, valuation and liquidity can prevent a position on their own. The remaining four inform timing, sizing and monitoring, and never reject an investment by themselves.

Bottom line

The gap between what today's price requires and what the business has demonstrated is -49.6 percentage points, and that gap — not the multiple — is the case that the security is mispriced. The most important unresolved uncertainty is the permanent-loss mechanism: bitcoin price and GPU residual value, against a balance sheet that has been levered since the last underwriting. The next evidence that should change the portfolio decision is the next scheduled results, or a daily close below $2.17, which forces an immediate review.